The Journal of Urology contains 4 sections: Adult Urology, Pediatric Urology,
Investigative Urology and Urological Survey.
Rapid Communications are welcomed.
The Clinical Section usually does not publish laboratory animal
studies. The Investigative Section
does not publish clinically oriented articles,
and does not require prior approval for Review Articles. Unsolicited material is
not accepted
for Urological Survey.
Submission of single case reports is discouraged. The decision to
publish a single case report will
be based on its relevance to advancing
the practice of urology.
All communications concerning editorial matters should be
sent to:
The Journal of Urology
Publications Department
American Urological Association
1000 Corporate Boulevard
Linthicum, MD 21090
Telephone (410) 689-3922, FAX (410) 689-3906
e-mail: publications@auanet.org
MANUSCRIPT
SUBMISSION. Authors must submit their manuscripts
through the Web-based tracking system at https://www.editorialmanager.com/ju
.
The site contains instructions and advice on how to use the system, guidance on
the creation/scanning and saving of electronic art,
and supporting documentation.
In addition to allowing authors to submit manuscripts on the Web, the site
allows authors to follow the
progression of their manuscript through the peer
review process. Authors are asked NOT to mail hard copies of the manuscript to
the editorial office. They may, however, mail to the editorial office any material
that cannot be submitted electronically.
For
potentially acceptable manuscripts, the period between receipt of
all reviews and when an editorial decision is made is usually longer.
AUTHOR'S RESPONSIBILITY. Manuscripts must be accompanied by a
cover letter, an AUA
Disclosure Form and an Author
Submission Requirement Form
(see last page) signed by all authors. The letter should include the complete
address, telephone
number, FAX number and e-mail address of the designated
corresponding author as well as the names of potential reviewers. The corresponding
author is responsible for indicating the source of extra-institutional
funding, in particular that provided by commercial sources, internal
review
board approval of study, accuracy of the references and all statements made in
their work, including changes made by the copy
editor.
Manuscripts submitted without all signatures on all statements will
be returned to the authors immediately. Electronic
signatures are acceptable.
Authors are expected to submit complete and correct manuscripts. Due to the
large number of high
quality articles being submitted and to avoid significant
delay in publication, the Editors find it necessary to insist that the length
of
manuscripts, and number of references and illustrations conform to the requirements
indicated herein. No paper will be reviewed until
these requirements are
met. Published manuscripts become the sole property of The Journal of Urology®
and copyright
will be taken out in the name of the American Urological
Association Education and Research, Inc.
All accepted NIH funded articles
must be directly deposited to
PubMed Central by the authors of the article for public access 12 months
after the publication date.
PAGE PROOFS AND CORRECTIONS. The corresponding author will
receive electronic page proofs to check the typeset article before
publication.
Portable document format (PDF) files of the typeset pages and support documents
(eg, reprint order form) will be sent to
the corresponding author by e-mail.
Complete instructions will be provided with the e-mail for downloading and
printing the files and
for faxing the corrected page proofs to the editorial office.
It is the author's responsibility to ensure that there are no errors
in the
proofs. Changes that have been made to conform to journal style will stand if they
do not alter the author's meaning. Only the
most critical changes to the accuracy
of the content will be made. Changes that are stylistic or are a reworking of
previously accepted
material will be disallowed. The editorial office reserves the
right to disallow extensive alterations. Authors may be charged for alterations
to
the proofs beyond those required to correct errors or to answer queries. Proofs
must be checked carefully and corrections faxed within
24 to 48 hours of receipt,
as requested in the cover letter accompanying the page proofs.
Rapid Review Manuscripts that contain
important and timely information
will be reviewed by 2 consultants and the editors within 72 hours of receipt,
and authors will be notified
of the disposition immediately thereafter. If and
when accepted these articles will be scheduled in the next available issue. A $250
processing fee should be forwarded with the manuscript at the time of submission.
Checks should be made payable to the American Urological
Association. If
the editors decide that the paper does not warrant rapid review, the fee will be
returned to the authors, and they may
elect to have the manuscript continue
through the standard review process. Payment for rapid review guarantees only
an expedited review
and not acceptance.
Original Articles should be arranged as follows: Title Page, Abstract,
Introduction, Materials and Methods,
Results, Discussion, Conclusions, References,
Tables, Legends. The title page should contain a concise, descriptive title,
the names
and affiliations of all authors, and a brief descriptive runninghead not
to exceed 50 characters. One to five key words should be typed
at the bottom of
the title page. These words should be identical to the medical subject headings
(MeSH) that appear in the Index Medicus
of the National Library of Medicine.
The abstract should not exceed 250 words and must conform to the following
style: Purpose, Materials
and Methods, Results and Conclusions.
References should not exceed 20 readily available citations for all original
articles
(except Review Articles). Self-citations should be kept to a minimum.
References should be cited by superscript numbers as they appear
in the text,
and they should not be alphabetized. References should include the names and
initials of the first 6 authors, the complete
title, the abbreviated journal name
according to the Index Medicus of the National Library of Medicine, the volume,
the beginning page
number and the year. References to book chapters should
include names and initials of the first 6 chapter authors, chapter title, book
title
and edition, names and initials of the first 6 book editors, city of publisher,
publisher, volume number, chapter number, page
range and year. In addition to
the above, references to electronic publications should include type of medium,
availability statement
and date of accession. The statistical methods should be
indicated and referenced. Enough information should be presented to allow an
independent critical assessment of the data.
Digital illustrations and tables should be kept to a necessary minimum
and their
information should not be duplicated in the text. No more than 10
illustrations should accompany the manuscript for clinical articles.
Magnifications
for photomicrographs should be supplied and graphs should be labeled
clearly. Reference to illustrations, numbered with
Arabic numerals, must be
provided in the text. Blurry or unrecognizable illustrations are not acceptable.
Visit http://rapidinspector.cadmus.com/zww
for detailed instructions for digital
art. The use of color is encouraged at no charge to the authors. Tables should
be numbered and
referred to in the text. In general, they should present
summarized rather than individual raw data.
Letters to the Editor
should be useful to urological practitioners. The
length should not exceed 500 words. Only Letters concerning articles published
in the
Journal within the last year are considered.
Review Articles should not be submitted without prior approval. Queries
for these
articles should be accompanied by a detailed outline of the proposed
article, an abstract not to exceed 750 words and an estimate of
the length of the
manuscript to be submitted. The format is the same as that of an Original
Article.
Video Clips may be submitted
for posting on The Journal web site. They are
subject to peer review. Video files must be compressed to the smallest possible
size that
still allows for high resolution and quality presentation. The size of each
clip should not exceed 10MB. File size limitation is intended
to ensure that
end-users are able to download and view files in a reasonable time frame. If files
exceed the specified size limitation,
they will not be posted to the web site and
returned to the author for resubmission. For complete instructions e-mail:publications@auanet.org.
Recommendations
1. All subgroup analyses and covariate inclusions should be motivated prior to the Results section. Hypotheses which were not
established
prior to initial analyses should be clearly identified.
2. Variables should be clearly defined, such as specific assays, references
for staging, references for validation of survey
instruments, etc.
3. Treatment regimens should be described well enough for another
study to replicate.
4. It should be clear which statistical test is associated with each p value reported.
5. Rarely used statistical
techniques should be described.
6. Medians and percentiles (such as quartiles) are preferred over means and standard deviations (or
standard errors) when
analyzing asymmetric data, especially when nonparametric statistics are calculated.
7. Fractions (eg, 5/10)
should accompany percentages.
8. In randomized clinical trials, consider reporting separate analyses with confounding variables included.
9. If sample sizes differ between groups when patients are randomized, reasons should be provided.
10. Report median survival (using
Kaplan-Meier) rather than mean survival if any data are censored.
11. Comparing survival functions (eg, with a log rank test) is more
efficient than analyzing particular time estimates (eg, 5-year
survival).
12. Use appropriate figures. Scatter plots are useful
for illustrating important correlations between variables. If subjects are
repeated in a figure (eg, over time), an individual's set
of points should be joined with line segments. Different symbols should
be used when points are stacked on top of each other. Illustrations
of regression lines should be overlaid on raw data.
Regression lines should not extend beyond the range of the predictor variable.
13. Confidence intervals are more appropriate than standard errors for comparison of groups.
14. Use appropriate tables. Coefficients
and standard errors are useful for interpreting regression predictors. One significant
figure beyond the level measured is sufficient
for means, standard deviations, standard errors, etc. One decimal place for
percentages greater than 1% is sufficient; no decimal places
if the sample size is less than 100. Two significant figures for test
statistics and p values are sufficient. Means should generally
be accompanied by some measure of their uncertainty, such as
confidence intervals or standard errors.
15. Confidence intervals should
be reported when possible.
16. When a statistical hypothesis test is not rejected, the actual p value (eg, 0.07) should be reported
(if known) rather than omitted
or reported as p>0.05.
17. Pay close attention to wording. The word "correlation" is generally
reserved for computing correlation coefficients. The word
"association" is usually preferred. Statistical tests can be nonparametric;
data cannot. Studies with negative findings (ie, no
difference) may be the result of low statistical power (eg, small sample size), rather
than absence of a difference, and this
limitation should be made clear. Trends that are not statistically significant should not be identified.
A p value is the
probability of observing data as extreme as those reported if the null hypothesis of no difference is true. A p value
is not the
probability of no real effect, nor is it necessarily related to the clinical importance.
Manuscript Checklist
• 1. Author Submission Requirement
form has been signed by all authors. • 2. AUA
Disclosure Form has been signed by all authors. • 3. Manuscript word count is provided. • 4. Manuscript
does not exceed 2,500 words for Original Article or 500 words for Letter to the Editor. • 5. No more than 10 illustrations submitted.
• 6. Standard abbreviations are defined in a key at the end of the manuscript, and are consistent throughout the text. •
7. Generic names are used for all drugs. Trade names are avoided. • 8. Normal laboratory values are provided in parentheses
when first used. • 9. The number of authors is limited to 6; if more than that number the senior author has justified inclusion
of each individual. • 10. Research or project support/funding is noted. • 11. Internal review board approval of study
is indicated. • 12. References are accurate, complete and in numerical order as they appear in the text, only the first 6 authors
are listed. • 13. No more than 20 references are cited, including references from the last 3 years. • 14. A corresponding
author and complete address, telephone and FAX numbers and e-mail address are provided. • 15. Written permission from publishers
to reproduce or adapt previously published illustrations or tables is included. • 16. Informed consent forms for identifiable
patient descriptions, photographs and pedigrees are included. • 17. Analytical reporting checklist completed. • 18.
Gender and minorities are identified in collection and analyses of data. • 19. Abbreviations for human genes are written in
italicized capital letters; protein products are written in capital letters and
are not italicized. • 20. Abbreviations for
animal genes are written in italics with only the first letter capitalized; protein products are written with
only the first letter capitalized
and are not italicized.
